Mirati To Challenge EMA’s Rejection Of US-Approved Krazati

Drug Was Granted Accelerated Approval By US FDA In December 2022

 
• By Neena Brizmohun
Concept of EMA European Medicines Agency. Drugs evaluation and quality control.
The EMA says Krazati should not be approved in the EU • Source: Shutterstock

More from Europe

More from Geography